Status:
COMPLETED
Cardiopulmonary Capacity and Quality of Life in Patients With Chronic Heart Failure
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Heart Failure is a progressive disorder that begins after an insult to the heart muscle resulting in the loss of functional cardiomyocytes, or even compromising the ability of the myocardium to contra...
Detailed Description
Individuals with cardiac heart failure, in functional class II and III (according to the New York Heart Association), residents of the metropolitan region of Porto Alegre, of both genders and aged ≥ 1...
Eligibility Criteria
Inclusion
- Individuals resident in Porto Alegre and metropolitan area,
- aged ≥ 18 years;
- with diagnosis of heart failure class II and III (New York Heart Association);
- clinically stable at least 3 months prior to the start of the study;
- with left ventricular ejection fraction (LV) ≤ 45%;
- under optimized pharmacological treatment;
- with resting heart rate ˂ 120 bpm;
- resting blood pressure ˂ 180 / 110mm Hg;
- previously sedentary.
Exclusion
- Decompensated heart failure (evidenced by ascites, lower limb edema, jugular swelling and / or pulmonary wheezing);
- individuals with decompensated metabolic diseases;
- acute coronary syndrome (ACS);
- survivors of sudden death;
- with acute myocardial infarction (AMI) and / or cardiac surgery for less than 6 months; -
- severe valvulopathies and / or cardiac arrhythmias;
- presence of asymmetric septal hypertrophic cardiomyopathy with dynamic outlet obstruction;
- with general contraindication criteria for performing the cardiopulmonary exercise test; -
- musculoskeletal disorders that limit exercise performance;
- with cognitive alterations that compromise the understanding of the stages and the execution of the research.
Key Trial Info
Start Date :
March 6 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT03321682
Start Date
March 6 2017
End Date
November 30 2020
Last Update
July 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HCPortoAlegre
Pôrto Alegre, Rio Grande do Sul, Brazil, 90035- 903